-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OqZ9SKxeRVmecAamIMLN9xl0A03LwNQKDaBdbRS20MvPLSy4FO73jzGgz7zNcSCl lKn7X0LmSSfQ4onOVIKpkg== 0000950144-03-002110.txt : 20030219 0000950144-03-002110.hdr.sgml : 20030219 20030219162510 ACCESSION NUMBER: 0000950144-03-002110 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20030219 ITEM INFORMATION: Other events ITEM INFORMATION: Financial statements and exhibits FILED AS OF DATE: 20030219 FILER: COMPANY DATA: COMPANY CONFORMED NAME: WEBMD CORP /NEW/ CENTRAL INDEX KEY: 0001009575 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] IRS NUMBER: 943236644 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-24975 FILM NUMBER: 03572870 BUSINESS ADDRESS: STREET 1: RIVER DRIVE CENTER 2 STREET 2: 669 RIVER DR CITY: ELMWOOD PARK STATE: NJ ZIP: 07407 BUSINESS PHONE: 4088765000 MAIL ADDRESS: STREET 1: RIVER DRIVE CENTER 2 STREET 2: 669 RIVER DR CITY: ELMWOOD PARK STATE: NJ ZIP: 07407 FORMER COMPANY: FORMER CONFORMED NAME: HEALTHSCAPE CORP DATE OF NAME CHANGE: 19970404 FORMER COMPANY: FORMER CONFORMED NAME: HEALTHEON CORP DATE OF NAME CHANGE: 19980729 8-K 1 g80793e8vk.htm WEBMD CORPORATION WEBMD CORPORATION
Table of Contents

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

Current Report Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

February 19, 2003

Date of Report (Date of earliest event reported)

WEBMD CORPORATION

(Exact name of registrant as specified in its charter)
         
Delaware
(State or other jurisdiction of
incorporation)		   0-24975
(Commission File Number) 		  94-3236644
(I.R.S. Employer
Identification No.)

669 River Drive, Center 2
Elmwood Park, New Jersey 07407-1361

(Address of principal executive offices, including zip code)

(201) 703-3400

(Registrant’s telephone number, including area code)

(Former name or address, if changed since last report)

 

SIGNATURE
EXHIBIT INDEX
EX-99.1 PRESS RELEASE

Table of Contents

ITEM 5.      OTHER EVENTS

     Attached hereto as Exhibit 99.1 and incorporated by reference herein is a press release issued by WebMD Corporation on February 19, 2003 announcing its fourth quarter earnings release date and the termination of its plan to divest Porex, its plastics technologies business.

ITEM 7.      FINANCIAL STATEMENTS AND EXHIBITS

  (c)   Exhibits
 
      The following exhibit is filed herewith:
 
      99.1       Press Release issued by WebMD Corporation, dated February 19, 2003.

2

Table of Contents

SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, WebMD Corporation has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

         
    WEBMD CORPORATION
         
         
Dated: February 19, 2003   By:   /s/ Lewis H. Leicher
     
      Lewis H. Leicher
Senior Vice President

3

Table of Contents

EXHIBIT INDEX

     
Exhibit    
Number   Description
 
99.1   Press Release issued by WebMD Corporation, dated February 19, 2003.

4 EX-99.1 3 g80793exv99w1.txt EX-99.1 PRESS RELEASE EXHIBIT 99.1 Contacts: Investors: Risa Fisher rfisher@webmd.net 201-414-2002 Media: Jennifer Meyer jmeyer@webmd.net 212-624-3912 WEBMD ANNOUNCES FOURTH QUARTER EARNINGS RELEASE DATE AND TERMINATION OF THE DIVESTITURE PROCESS FOR POREX ELMWOOD PARK, NEW JERSEY (FEBRUARY 19, 2003) - WebMD Corporation (NASDAQ: HLTH) announced today that it will release financial results for the three months ended December 31, 2002 at approximately 4:00 pm (ET) on March 13, 2003. The Company will host a conference call at 4:45 pm (ET) on that day to discuss these results. Investors can access the call via webcast at www.webmd.com (in the About WebMD section). WebMD Corporation also announced today its decision to terminate its plan to divest Porex, its plastics technologies business. WebMD believes that the offers it has received do not reflect an appropriate value for Porex and, accordingly has decided to terminate any further efforts to divest Porex at this time. WebMD had classified Porex as an asset held for sale in its financial statements. As a result of the termination of its divestiture efforts, WebMD will reclassify Porex as a continuing operation in its financial statements for both prior and future periods. Porex will be shown as a business segment and its revenues, expenses, net income, balance sheet and cash flows will be included in WebMD's consolidated financial statements with WebMD's other business segments. William G. Midgette, Chief Executive Officer of Porex, said, "Our proprietary technology and advanced manufacturing capabilities have made Porex a valued partner to a wide range of original equipment manufacturers, including manufacturers of medical devices and diagnostic products. We have several exciting new applications that are being rolled out and others in various stages of development. These applications include a new porous plastic material for lateral flow immunoassays for use in a number of diagnostic testing markets, a new product that provides superior fluid dynamics for photo quality computer printers and a fluid collection product for use in testing for, among other things, HIV antibodies. Although Porex is currently being impacted by increased competitive pressures in certain of its markets, we believe that these new product applications will create significant revenue and growth opportunities in the future." Martin J. Wygod, Chairman and CEO of WebMD, said, "We believe that the offers we received for Porex did not reflect the potential value of the new product applications being developed. We are very excited about the opportunities in the Porex business and intend to work with the dedicated team of management and employees of Porex to maximize the value of Porex to the WebMD shareholders." ABOUT WEBMD WebMD Corporation provides services that help physicians, consumers, providers and health plans navigate the complexity of the healthcare system. Our products and services streamline administrative and clinical processes, promote efficiency and reduce costs by facilitating information exchange, communication and electronic transactions between healthcare participants. WebMD Health is the leading provider of online information, educational services and communities for physicians and consumers. WebMD Medical Manager is the leading provider of physician practice management software and related services. WebMD Envoy is the leading provider of electronic data interchange services for healthcare providers and commercial health plans. ABOUT POREX Porex is developer, manufacturer and distributor of proprietary porous and solid plastics products and components used in healthcare, industrial and consumer applications. Porex customers include both end-users of its finished products as well as manufacturers that include Porex components in their products. Porex is owned by WebMD. * * * * All statements contained in this press release, other than statements of historical fact, are forward-looking. These statements are based on WebMD's current plans and expectations and involve risks and uncertainties that could cause actual future events or results to be different from those described in or implied by such forward-looking statements. These risks and uncertainties include those relating to: market acceptance of products and services; profit potential of strategic and customer relationships; and economic conditions and regulatory matters affecting the information technology, Internet and healthcare industries. Further information about these matters can be found in WebMD's Securities and Exchange Commission filings. WebMD expressly disclaims any intent or obligation to update these forward-looking statements. 2 -----END PRIVACY-ENHANCED MESSAGE-----